Nucleic Acid Test versus Enzyme Linked Immunosorbent Assay for Screening of Human Immunodeficiency Virus in Donated Blood Units: A Comparative Study at a Blood Centre in Western Rajasthan, India

Introduction: With a population of 1.3 billion people and a frequency of Human Immunodeficiency Virus (HIV) (0.17-0.29%), Hepatitis B Virus (HBV) (3-4%), and Hepatitis C Virus (HCV) (0.09-15%) in the general population, maintaining blood safety is a difficult undertaking in India. The fourth generat...

Full description

Bibliographic Details
Main Authors: Rishi Mathur, NL Mahawar, DR Arya, Arun Bharti
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2022-09-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://www.jcdr.net/articles/PDF/16846/57260_F(KM)_PF1(AG_OM)_PN(KM).pdf
_version_ 1811176424677048320
author Rishi Mathur
NL Mahawar
DR Arya
Arun Bharti
author_facet Rishi Mathur
NL Mahawar
DR Arya
Arun Bharti
author_sort Rishi Mathur
collection DOAJ
description Introduction: With a population of 1.3 billion people and a frequency of Human Immunodeficiency Virus (HIV) (0.17-0.29%), Hepatitis B Virus (HBV) (3-4%), and Hepatitis C Virus (HCV) (0.09-15%) in the general population, maintaining blood safety is a difficult undertaking in India. The fourth generation Enzyme Linked Immunosorbent Assay (ELISA), which can be used in place of Nucleic Acid Amplification Test (NAT) testing in situations with limited resources, has been recommended as the minimal HIV test to increase the safety of blood transfusions. Aim: To compare the fourth generation ELISA with NAT in the screening of transfusion transmissible HIV infection in blood donors. Materials and Methods: A cross-sectional study was carried out at the Blood Centre, Department of Immunohaematology and Transfusion Medicine, Sardar Patel Medical College and Associated Groups of Hospitals, in Bikaner, Rajasthan, India. A total of 2000 voluntary and replacement blood donors were recruited consecutively between January 2020 to December 2021 (two years), and their samples were screened using fourth generation ELISA. All of these samples were sent to AIIMS in Jodhpur for NAT to identify HIV RNA, HCV RNA and HBV DNA. Results: In this study, when the fourth generation ELISA negative samples were subjected to NAT, no sample was found to be reactive for HIV in NAT, i.e. there was no NAT yield for HIV. Conclusion: As a bare minimum, the fourth generation ELISA test should be used for blood donor screening and can be considered a cost-effective and reliable test in a resource limited setting. However, additional tests can be advocated for an additional layer of blood safety.
first_indexed 2024-04-10T19:51:17Z
format Article
id doaj.art-08a9519f33e94eec8441b9604bcd96c9
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-04-10T19:51:17Z
publishDate 2022-09-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-08a9519f33e94eec8441b9604bcd96c92023-01-28T04:54:19ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2022-09-01169EC16EC2110.7860/JCDR/2022/57260.16846Nucleic Acid Test versus Enzyme Linked Immunosorbent Assay for Screening of Human Immunodeficiency Virus in Donated Blood Units: A Comparative Study at a Blood Centre in Western Rajasthan, IndiaRishi Mathur0NL Mahawar1DR Arya2Arun Bharti3Resident, Department of Immnohaematology and Transfusion Medicine, Sardar Patel Medical College, Bikaner, Rajasthan, India.Professor, Department of Immnohaematology and Transfusion Medicine, Sardar Patel Medical College, Bikaner, Rajasthan, India.Senior Professor, Department of Immnohaematology and Transfusion Medicine, Sardar Patel Medical College, Bikaner, Rajasthan, India.Associate Professor, Department of Immnohaematology and Transfusion Medicine, Sardar Patel Medical College, Bikaner, Rajasthan, India.Introduction: With a population of 1.3 billion people and a frequency of Human Immunodeficiency Virus (HIV) (0.17-0.29%), Hepatitis B Virus (HBV) (3-4%), and Hepatitis C Virus (HCV) (0.09-15%) in the general population, maintaining blood safety is a difficult undertaking in India. The fourth generation Enzyme Linked Immunosorbent Assay (ELISA), which can be used in place of Nucleic Acid Amplification Test (NAT) testing in situations with limited resources, has been recommended as the minimal HIV test to increase the safety of blood transfusions. Aim: To compare the fourth generation ELISA with NAT in the screening of transfusion transmissible HIV infection in blood donors. Materials and Methods: A cross-sectional study was carried out at the Blood Centre, Department of Immunohaematology and Transfusion Medicine, Sardar Patel Medical College and Associated Groups of Hospitals, in Bikaner, Rajasthan, India. A total of 2000 voluntary and replacement blood donors were recruited consecutively between January 2020 to December 2021 (two years), and their samples were screened using fourth generation ELISA. All of these samples were sent to AIIMS in Jodhpur for NAT to identify HIV RNA, HCV RNA and HBV DNA. Results: In this study, when the fourth generation ELISA negative samples were subjected to NAT, no sample was found to be reactive for HIV in NAT, i.e. there was no NAT yield for HIV. Conclusion: As a bare minimum, the fourth generation ELISA test should be used for blood donor screening and can be considered a cost-effective and reliable test in a resource limited setting. However, additional tests can be advocated for an additional layer of blood safety.https://www.jcdr.net/articles/PDF/16846/57260_F(KM)_PF1(AG_OM)_PN(KM).pdfamplification testblood donorssafety
spellingShingle Rishi Mathur
NL Mahawar
DR Arya
Arun Bharti
Nucleic Acid Test versus Enzyme Linked Immunosorbent Assay for Screening of Human Immunodeficiency Virus in Donated Blood Units: A Comparative Study at a Blood Centre in Western Rajasthan, India
Journal of Clinical and Diagnostic Research
amplification test
blood donors
safety
title Nucleic Acid Test versus Enzyme Linked Immunosorbent Assay for Screening of Human Immunodeficiency Virus in Donated Blood Units: A Comparative Study at a Blood Centre in Western Rajasthan, India
title_full Nucleic Acid Test versus Enzyme Linked Immunosorbent Assay for Screening of Human Immunodeficiency Virus in Donated Blood Units: A Comparative Study at a Blood Centre in Western Rajasthan, India
title_fullStr Nucleic Acid Test versus Enzyme Linked Immunosorbent Assay for Screening of Human Immunodeficiency Virus in Donated Blood Units: A Comparative Study at a Blood Centre in Western Rajasthan, India
title_full_unstemmed Nucleic Acid Test versus Enzyme Linked Immunosorbent Assay for Screening of Human Immunodeficiency Virus in Donated Blood Units: A Comparative Study at a Blood Centre in Western Rajasthan, India
title_short Nucleic Acid Test versus Enzyme Linked Immunosorbent Assay for Screening of Human Immunodeficiency Virus in Donated Blood Units: A Comparative Study at a Blood Centre in Western Rajasthan, India
title_sort nucleic acid test versus enzyme linked immunosorbent assay for screening of human immunodeficiency virus in donated blood units a comparative study at a blood centre in western rajasthan india
topic amplification test
blood donors
safety
url https://www.jcdr.net/articles/PDF/16846/57260_F(KM)_PF1(AG_OM)_PN(KM).pdf
work_keys_str_mv AT rishimathur nucleicacidtestversusenzymelinkedimmunosorbentassayforscreeningofhumanimmunodeficiencyvirusindonatedbloodunitsacomparativestudyatabloodcentreinwesternrajasthanindia
AT nlmahawar nucleicacidtestversusenzymelinkedimmunosorbentassayforscreeningofhumanimmunodeficiencyvirusindonatedbloodunitsacomparativestudyatabloodcentreinwesternrajasthanindia
AT drarya nucleicacidtestversusenzymelinkedimmunosorbentassayforscreeningofhumanimmunodeficiencyvirusindonatedbloodunitsacomparativestudyatabloodcentreinwesternrajasthanindia
AT arunbharti nucleicacidtestversusenzymelinkedimmunosorbentassayforscreeningofhumanimmunodeficiencyvirusindonatedbloodunitsacomparativestudyatabloodcentreinwesternrajasthanindia